CHM 11.1% 2.0¢ chimeric therapeutics limited

My EGM question was why he hasn't used the GBM Ph1 data back...

  1. 12,293 Posts.
    lightbulb Created with Sketch. 3760
    My EGM question was why he hasn't used the GBM Ph1 data back then to achieve a higher CR price and he answered like " You can't just raise at 10c because we are doing a trial. "

    Anyway, you can sell anything if the price is right and the RAD trial data are as great in their field as CHM's in its field. As I always demanded, don't sell the comps too short as it back fires. Don't hide the gems, make them count when needed. Not saying he was listening to me, definitely not, but maybe someone else brought him back on track.

    Let's see if suddenly Amgen or Kite or Jen's new employer come to the party.

    GLTA
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.002(11.1%)
Mkt cap ! $17.25M
Open High Low Value Volume
1.9¢ 2.0¢ 1.9¢ $26.18K 1.372M

Buyers (Bids)

No. Vol. Price($)
7 736556 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 1462067 5
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.